BackgroundA greater understanding of the determinants of health behavior among those with and at-risk of chronic hepatitis B virus (HBV) infection is needed for effective design and implementation of public health initiatives.AimsTo determine factors associated with (1) willingness to accept HBV antiviral treatment and (2) satisfaction with provider communication regarding HBV care in a diverse cohort of HBV-infected patients.MethodsUsing a multifaceted model of health behavior, the Health Behavior Framework, we conducted a comprehensive assessment of knowledge, attitudes, beliefs, and barriers to HBV care.ResultsWe enrolled 510 patients, with mean age 46 years; 53.1% men; and 71.6% Asian or Hawaiian/Pacific Islander. Patients were kno...
An estimated 170 million people worldwide have hepatitis C, which is a significant cause of morbidit...
Prejudice and discrimination in the workplace regarding the risk of transmission of Hepatitis B viru...
Background: In Australia, only 22% of people with chronic hepatitis B (CHB) are clinically managed; ...
GoalsTo evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and mana...
Background: Hepatitis B (HBV) is the leading cause of cirrhosis and hepatocellular carcinoma worldwi...
BACKGROUND: Current estimates suggest over 218,000 individuals in Australia are chronically infected...
This study was conducted to understand the symptomatology, attitudes, and behaviours of chronic hepa...
Aim: Hepatitis B (HBV) infection is one of the most important public health problems throughout the...
BACKGROUND AND AIM:Vietnam's burden of liver cancer is largely due to its high prevalence of chronic...
Patients with hepatitis B face uncertainty at diagnosis. Information and support they receive at the...
Asians have the highest prevalence of all ethnic groups as chronic carriers of hepatitis B but up to...
Introduction: Chronic hepatitis B can lead to life-threatening complications, including liver failur...
Chronic hepatitis B virus (HBV) disproportionately affects Asian Americans and Pacific Islanders. Th...
Background: Healthcare workers infected with Hepatitis B (HBV) or Hepatitis C virus (HCV) may undert...
BACKGROUND: The novel coronavirus of 2019 (COVID-19) has been and continues to be a rapidly developi...
An estimated 170 million people worldwide have hepatitis C, which is a significant cause of morbidit...
Prejudice and discrimination in the workplace regarding the risk of transmission of Hepatitis B viru...
Background: In Australia, only 22% of people with chronic hepatitis B (CHB) are clinically managed; ...
GoalsTo evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and mana...
Background: Hepatitis B (HBV) is the leading cause of cirrhosis and hepatocellular carcinoma worldwi...
BACKGROUND: Current estimates suggest over 218,000 individuals in Australia are chronically infected...
This study was conducted to understand the symptomatology, attitudes, and behaviours of chronic hepa...
Aim: Hepatitis B (HBV) infection is one of the most important public health problems throughout the...
BACKGROUND AND AIM:Vietnam's burden of liver cancer is largely due to its high prevalence of chronic...
Patients with hepatitis B face uncertainty at diagnosis. Information and support they receive at the...
Asians have the highest prevalence of all ethnic groups as chronic carriers of hepatitis B but up to...
Introduction: Chronic hepatitis B can lead to life-threatening complications, including liver failur...
Chronic hepatitis B virus (HBV) disproportionately affects Asian Americans and Pacific Islanders. Th...
Background: Healthcare workers infected with Hepatitis B (HBV) or Hepatitis C virus (HCV) may undert...
BACKGROUND: The novel coronavirus of 2019 (COVID-19) has been and continues to be a rapidly developi...
An estimated 170 million people worldwide have hepatitis C, which is a significant cause of morbidit...
Prejudice and discrimination in the workplace regarding the risk of transmission of Hepatitis B viru...
Background: In Australia, only 22% of people with chronic hepatitis B (CHB) are clinically managed; ...